About Nuvvagen Bioscience Private Limited
Data last updated:
Nuvvagen Bioscience Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the preventive health supplements segment of the healthcare sector. It was incorporated on 19 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24234MH2019PTC330749. Its GSTIN is 27AAGCN6900K1Z9 (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Dhavall Sangani and Vasant Vallabhdas Sangani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 233 Blue Rose Industrial Estate Western Express Highway Borivali East, Mumbai, Maharashtra, India – 400066.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.35 Cr, a decline of 51% compared to the previous year. For the same year it recorded a net loss of ₹1.41 Cr (net margin -104.4%) and EBITDA of -₹1.41 Cr (EBITDA margin -104.1%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years.
The company has about 16 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.95 Cr on record.
For more details, the company can be reached via its website nuvvagen.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address233 Blue Rose Industrial Estate Western Express Highway Borivali East, Mumbai, Maharashtra, India – 400066
- IndustryHealthcare, Preventive Health Supplements
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nuvvagen Bioscience Private Limited
The main business activity of Nuvvagen Bioscience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nuvvagen Bioscience Private Limited FY 2025 filings available
Nuvvagen Bioscience Private Limited reported revenue of ₹1.35 Cr (down 51% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Nuvvagen Bioscience Private Limited
Revenue fell 51% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 11%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nuvvagen Bioscience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.41 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.41 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nuvvagen Bioscience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -104.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -104.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nuvvagen Bioscience are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Nuvvagen Bioscience Private Limited
Nuvvagen Bioscience Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Supplements). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jeevanjyoti Life Line Centre Private Limited | ₹1.4 Cr (FY 2024) | •••• | •••• | 40.0% | •••• | Saharanpur, Uttar Pradesh, India |
| Evalin Healthcare Private Limited | ₹1.38 Cr (FY 2025) | •••• | •••• | 37.0% | •••• | Kanpur, Uttar Pradesh, India |
| Mespa Health Care Private Limited | ₹1.38 Cr (FY 2025) | •••• | •••• | 20142.0% | •••• | Agra, Uttar Pradesh, India |
| Biozeal Lifesciences Private Limited | ₹1.37 Cr (FY 2025) | •••• | •••• | 53.0% | •••• | Vasai, Maharashtra, India |
| Lake Shore Realty Limited Listed | ₹1.36 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | New Delhi, Delhi, India |
| Nuvvagen Bioscience Private Limited this company | ₹1.35 Cr (FY 2025) | •••• | •••• | -51.0% | •••• | Mumbai, Maharashtra, India |
| Xania Healthcare Private Limited | ₹1.35 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Ahmedabad, Gujarat, India |
| Bake Nutrition Private Limited | ₹1.33 Cr (FY 2025) | •••• | •••• | 117.0% | •••• | Delhi, India |
| Pm-International India Private Limited | ₹1.33 Cr (FY 2025) | •••• | •••• | 150.0% | •••• | New Delhi, Delhi, India |
| Alphahealth Lifesciences Private Limited | ₹1.32 Cr (FY 2025) | •••• | •••• | 273.0% | •••• | Ambarnath, Maharashtra, India |
| Meneki Nutrition Private Limited | ₹1.31 Cr (FY 2024) | •••• | •••• | 83.0% | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Nuvvagen Bioscience by revenue in the Healthcare industry (Preventive Healthcare Supplements), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nuvvagen Bioscience Private Limited
Nuvvagen Bioscience Private Limited is audited by VISHAL KANAIYALAL RAVAL for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VISHAL KANAIYALAL RAVAL | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Nuvvagen Bioscience Private Limited
Nuvvagen Bioscience has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhavall Sangani Also directs: Vajrachem India Limited | Director | 19 Sep 2019 | 7 Years 0 Months | Current |
| Vasant Vallabhdas Sangani | Director | 19 Sep 2019 | 7 Years 0 Months | Current |
Ownership and Shareholding of Nuvvagen Bioscience Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nuvvagen Bioscience Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Aug 2025 | Hdfc Bank Limited | ₹4.95 Cr | Open |
Total charge records: 1 View all charges
MSME Payment Delays by Nuvvagen Bioscience Private Limited
Nuvvagen Bioscience Private Limited has 2 MSME Form 1 returns on record for the period ending Sep 2021, listing 14 overdue payments to 11 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 11)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| New Indraprstha | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Chembur Hospital and Iccu LLP | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Sunil Pharma | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Nuvvagen Bioscience Private Limited
Nuvvagen Bioscience Private Limited has a workforce of 16 employees as of Dec 02, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nuvvagen Bioscience Private Limited
Nuvvagen Bioscience Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Dhavall Sangani was appointed as Director on 19 Sep 2019.
Credit Ratings, Litigation & Regulatory Alerts for Nuvvagen Bioscience Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nuvvagen Bioscience Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nuvvagen Bioscience Private Limited
Nuvvagen Bioscience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCN6900K1Z9 | Maharashtra | Active | 23 Oct 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nuvvagen Bioscience Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nuvvagen Bioscience Private Limited
Nuvvagen Bioscience is an active private limited company based in Mumbai, Maharashtra, India. The company works in preventive health supplements, within the healthcare industry. It was incorporated on 19 September 2019 (7+ years old) and is registered under CIN U24234MH2019PTC330749.
Nuvvagen Bioscience reported revenue of ₹1.35 Cr for FY 2025 (down 51% YoY).
Nuvvagen Bioscience has 2 current directors:
- Dhavall Sangani - Director
- Vasant Vallabhdas Sangani - Director
Nuvvagen Bioscience reported a net loss of ₹1.41 Cr (net margin -104.4%) and EBITDA of -₹1.41 Cr (EBITDA margin -104.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nuvvagen Bioscience is 11% over three years. In the latest year (FY 2025) revenue fell 51%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nuvvagen Bioscience is 27AAGCN6900K1Z9, registered in Maharashtra.
The CIN (Corporate Identification Number) of Nuvvagen Bioscience is U24234MH2019PTC330749. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nuvvagen Bioscience was incorporated on 19 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Nuvvagen Bioscience by revenue are Jeevanjyoti Life Line Centre Private Limited, Evalin Healthcare Private Limited, Mespa Health Care Private Limited, Biozeal Lifesciences Private Limited, Lake Shore Realty Limited and 5 more, all in the Healthcare industry (Preventive Healthcare Supplements).
Dhavall Sangani was appointed as Director on 19 Sep 2019. Vasant Vallabhdas Sangani was appointed as Director on 19 Sep 2019.
Nuvvagen Bioscience has 2 MSME Form 1 returns on record for the period ending Sep 2021, listing 14 overdue payments to 11 micro and small suppliers. The latest return was filed on 16 Oct 2021.
Nuvvagen Bioscience can be reached through the website nuvvagen.com. Its registered office is in Mumbai, Maharashtra, India.